Quest Diagnostics Incorporated (0KSX.L)
USD 173.4
(5.91%)
USD 173.4
(5.91%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 190 Million USD | -1.04% |
| 2022 | 192 Million USD | -7.69% |
| 2021 | 208 Million USD | -6.73% |
| 2020 | 223 Million USD | 81.3% |
| 2019 | 123 Million USD | 24.24% |
| 2018 | 99 Million USD | 4.21% |
| 2017 | 95 Million USD | 15.85% |
| 2016 | 82 Million USD | -2.38% |
| 2015 | 84 Million USD | -23.64% |
| 2014 | 110 Million USD | 20.88% |
| 2013 | 91 Million USD | -2.26% |
| 2012 | 93.1 Million USD | 4.49% |
| 2011 | 89.1 Million USD | 16.32% |
| 2010 | 76.6 Million USD | -16.19% |
| 2009 | 91.4 Million USD | -10.48% |
| 2008 | 102.1 Million USD | 7.21% |
| 2007 | 95.23 Million USD | 21.22% |
| 2006 | 78.56 Million USD | 0.8% |
| 2005 | 77.93 Million USD | 3.47% |
| 2004 | 75.32 Million USD | 3.92% |
| 2003 | 72.48 Million USD | 19.02% |
| 2002 | 60.89 Million USD | 22.03% |
| 2001 | 49.9 Million USD | 12.72% |
| 2000 | 44.27 Million USD | -15.35% |
| 1999 | 52.3 Million USD | 67.63% |
| 1998 | 31.2 Million USD | 2.63% |
| 1997 | 30.4 Million USD | 6.58% |
| 1996 | 28.52 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 182 Million USD | 0.55% |
| 2024 Q1 | 181 Million USD | -4.74% |
| 2024 Q3 | 184 Million USD | 1.1% |
| 2023 Q3 | 184 Million USD | 0.0% |
| 2023 Q2 | 184 Million USD | -3.16% |
| 2023 FY | 190 Million USD | -1.04% |
| 2023 Q4 | 190 Million USD | 3.26% |
| 2023 Q1 | 190 Million USD | -1.04% |
| 2022 FY | 192 Million USD | -7.69% |
| 2022 Q3 | 183 Million USD | -2.14% |
| 2022 Q4 | 192 Million USD | 4.92% |
| 2022 Q1 | 197 Million USD | -5.29% |
| 2022 Q2 | 187 Million USD | -5.08% |
| 2021 Q4 | 208 Million USD | 1.46% |
| 2021 Q3 | 205 Million USD | 3.02% |
| 2021 FY | 208 Million USD | -6.73% |
| 2021 Q1 | 223 Million USD | 0.0% |
| 2021 Q2 | 199 Million USD | -10.76% |
| 2020 Q2 | 154 Million USD | 22.22% |
| 2020 Q3 | 205 Million USD | 33.12% |
| 2020 FY | 223 Million USD | 81.3% |
| 2020 Q1 | 126 Million USD | 2.44% |
| 2020 Q4 | 223 Million USD | 8.78% |
| 2019 Q4 | 123 Million USD | 9.82% |
| 2019 FY | 123 Million USD | 24.24% |
| 2019 Q1 | 98 Million USD | -1.01% |
| 2019 Q2 | 105 Million USD | 7.14% |
| 2019 Q3 | 112 Million USD | 6.67% |
| 2018 Q3 | 95 Million USD | 4.4% |
| 2018 FY | 99 Million USD | 4.21% |
| 2018 Q4 | 99 Million USD | 4.21% |
| 2018 Q2 | 91 Million USD | -3.19% |
| 2018 Q1 | 94 Million USD | -1.05% |
| 2017 FY | 95 Million USD | 15.85% |
| 2017 Q2 | 83 Million USD | 7.79% |
| 2017 Q1 | 77 Million USD | -6.1% |
| 2017 Q4 | 95 Million USD | -5.0% |
| 2017 Q3 | 100 Million USD | 20.48% |
| 2016 FY | 82 Million USD | -2.38% |
| 2016 Q1 | 82 Million USD | -2.38% |
| 2016 Q2 | 80 Million USD | -2.44% |
| 2016 Q3 | 82 Million USD | 2.5% |
| 2016 Q4 | 82 Million USD | 0.0% |
| 2015 Q1 | 106 Million USD | -3.64% |
| 2015 Q3 | 86 Million USD | -21.1% |
| 2015 Q4 | 84 Million USD | -2.33% |
| 2015 FY | 84 Million USD | -23.64% |
| 2015 Q2 | 109 Million USD | 2.83% |
| 2014 Q3 | 111 Million USD | 1.83% |
| 2014 FY | 110 Million USD | 20.88% |
| 2014 Q1 | 99 Million USD | 8.79% |
| 2014 Q2 | 109 Million USD | 10.1% |
| 2014 Q4 | 110 Million USD | -0.9% |
| 2013 Q2 | 89.4 Million USD | -0.45% |
| 2013 Q4 | 91 Million USD | 6.81% |
| 2013 Q3 | 85.2 Million USD | -4.7% |
| 2013 Q1 | 89.8 Million USD | -3.54% |
| 2013 FY | 91 Million USD | -2.26% |
| 2012 FY | 93.1 Million USD | 4.49% |
| 2012 Q1 | 88.3 Million USD | -0.93% |
| 2012 Q2 | 90.1 Million USD | 2.04% |
| 2012 Q3 | 94.5 Million USD | 4.88% |
| 2012 Q4 | 93.1 Million USD | -1.48% |
| 2011 Q3 | 85 Million USD | -3.41% |
| 2011 Q1 | 71.7 Million USD | -6.36% |
| 2011 FY | 89.1 Million USD | 16.32% |
| 2011 Q4 | 89.13 Million USD | 4.86% |
| 2011 Q2 | 88 Million USD | 22.73% |
| 2010 Q1 | 79.5 Million USD | -13.01% |
| 2010 FY | 76.6 Million USD | -16.19% |
| 2010 Q3 | 73.2 Million USD | -6.63% |
| 2010 Q4 | 76.57 Million USD | 4.61% |
| 2010 Q2 | 78.4 Million USD | -1.38% |
| 2009 FY | 91.4 Million USD | -10.48% |
| 2009 Q1 | 86.5 Million USD | -15.3% |
| 2009 Q2 | 79.71 Million USD | -7.84% |
| 2009 Q3 | 80.9 Million USD | 1.49% |
| 2009 Q4 | 91.38 Million USD | 12.96% |
| 2008 Q1 | 97.36 Million USD | 2.24% |
| 2008 FY | 102.1 Million USD | 7.21% |
| 2008 Q4 | 102.12 Million USD | 3.35% |
| 2008 Q2 | 98.33 Million USD | 0.99% |
| 2008 Q3 | 98.81 Million USD | 0.5% |
| 2007 FY | 95.23 Million USD | 21.22% |
| 2007 Q1 | 87.71 Million USD | 11.65% |
| 2007 Q3 | 92.44 Million USD | -4.54% |
| 2007 Q4 | 95.23 Million USD | 3.01% |
| 2007 Q2 | 96.83 Million USD | 10.4% |
| 2006 Q2 | 71.46 Million USD | -8.28% |
| 2006 Q3 | 77.31 Million USD | 8.19% |
| 2006 Q4 | 78.56 Million USD | 1.62% |
| 2006 Q1 | 77.91 Million USD | -0.03% |
| 2006 FY | 78.56 Million USD | 0.8% |
| 2005 Q3 | 78.17 Million USD | 2.5% |
| 2005 Q4 | 77.93 Million USD | -0.3% |
| 2005 Q2 | 76.26 Million USD | 0.01% |
| 2005 Q1 | 76.26 Million USD | 1.24% |
| 2005 FY | 77.93 Million USD | 3.47% |
| 2004 FY | 75.32 Million USD | 3.92% |
| 2004 Q4 | 75.32 Million USD | 2.88% |
| 2004 Q3 | 73.21 Million USD | 0.51% |
| 2004 Q2 | 72.84 Million USD | 0.31% |
| 2004 Q1 | 72.62 Million USD | 0.19% |
| 2003 FY | 72.48 Million USD | 19.02% |
| 2003 Q4 | 72.48 Million USD | 5.93% |
| 2003 Q3 | 68.42 Million USD | -0.08% |
| 2003 Q2 | 68.48 Million USD | 2.11% |
| 2003 Q1 | 67.06 Million USD | 10.13% |
| 2002 Q4 | 60.89 Million USD | 3.19% |
| 2002 FY | 60.89 Million USD | 22.03% |
| 2002 Q3 | 59.01 Million USD | 1.87% |
| 2002 Q2 | 57.93 Million USD | 12.41% |
| 2002 Q1 | 51.53 Million USD | 3.26% |
| 2001 Q3 | 46.18 Million USD | 3.9% |
| 2001 FY | 49.9 Million USD | 12.72% |
| 2001 Q4 | 49.9 Million USD | 8.05% |
| 2001 Q1 | 45.16 Million USD | 2.0% |
| 2001 Q2 | 44.45 Million USD | -1.56% |
| 2000 Q1 | 49.9 Million USD | -4.58% |
| 2000 Q2 | 47.84 Million USD | -4.12% |
| 2000 Q4 | 44.27 Million USD | 2.93% |
| 2000 FY | 44.27 Million USD | -15.35% |
| 2000 Q3 | 43.01 Million USD | -10.11% |
| 1999 Q4 | 52.3 Million USD | 1.75% |
| 1999 FY | 52.3 Million USD | 67.63% |
| 1999 Q1 | 33 Million USD | 5.77% |
| 1999 Q2 | 32.9 Million USD | -0.3% |
| 1999 Q3 | 51.4 Million USD | 56.23% |
| 1998 FY | 31.2 Million USD | 2.63% |
| 1998 Q4 | 31.2 Million USD | 4.7% |
| 1998 Q1 | 30 Million USD | -1.32% |
| 1998 Q3 | 29.8 Million USD | 2.05% |
| 1998 Q2 | 29.2 Million USD | -2.67% |
| 1997 Q4 | 30.4 Million USD | 4.11% |
| 1997 Q2 | 27.9 Million USD | -2.45% |
| 1997 Q1 | 28.6 Million USD | -1.38% |
| 1997 FY | 30.4 Million USD | 6.58% |
| 1997 Q3 | 29.2 Million USD | 4.66% |
| 1996 Q4 | 29 Million USD | 11.54% |
| 1996 Q3 | 26 Million USD | 0.0% |
| 1996 FY | 28.52 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -37.359% |
| Align Technology, Inc. | 296.9 Million USD | 36.006% |
| Elevance Health Inc. | -46.33 Billion USD | 100.41% |
| AxoGen, Inc. | 23.02 Million USD | -725.369% |
| Boston Scientific Corporation | 2.48 Billion USD | 92.351% |
| CVS Health Corporation | 18.02 Billion USD | 98.946% |
| Cardinal Health, Inc. | 14.95 Billion USD | 98.73% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -32.77% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 90.599% |
| Hologic, Inc. | 679.8 Million USD | 72.051% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 50.037% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | 59.966% |
| Masimo Corporation | 545 Million USD | 65.138% |
| McKesson Corporation | 21.13 Billion USD | 99.101% |
| Patterson Companies, Inc. | 782.89 Million USD | 75.731% |
| ResMed Inc. | 822.25 Million USD | 76.893% |
| Henry Schein, Inc. | 1.81 Billion USD | 89.532% |
| Teladoc Health, Inc. | 29.51 Million USD | -543.784% |
| Universal Health Services, Inc. | 216.98 Million USD | 12.438% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 93.272% |
| Becton, Dickinson and Company | 3.27 Billion USD | 94.195% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 84.434% |
| Danaher Corporation | 2.59 Billion USD | 92.675% |
| Stryker Corporation | 4.84 Billion USD | 96.077% |
| Medtronic plc | 5.21 Billion USD | 96.358% |